Objectives
After participating in this educational activity, attendees should be able to:
1| Determine the pros and cons of clinical prediction models for DKD progression
2| Evaluate the utility of biomarker-enriched prognostic risk scores in DKD
3| Assess the value of biomarkers to determine response to various therapies in DKD
 
Faculty
Steven Coca, DO, MS
Associate Chair, Clinical and Translational Research, Department of Internal Medicine
Director of Clinical Research, Division of Nephrology
Professor of Medicine, Icahn School of Medicine at Mount Sinai
 
 
Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity. 

Steven Coca, DO, MS is the co-founder, and stock option holder for Renalytix. He is a consultant for the companies Renalytix, Bayer, Takeda, Boehringer-Ingelheim and Vifor.

None of the other planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

                                                                                                                                                



Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physicians
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Nurses
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 contact hour(s).  Nurses should only claim the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.  Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 1.0 AAPA Category 1 CME credits.  PA’s should only claim credit commensurate with the extent of their participation. 


This activity was planned by and for the healthcare team and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Session date: 
03/06/2024 - 8:00am to 9:00am EST
Location: 
Baystate Medical Center - Hybrid
759 Chestnut Street
Chestnut 1 A/B & Virtual
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.